Literature DB >> 34322849

Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons.

Anne Sofie Frølunde1, Jacob Pontoppidan Thyssen2, Mette Deleuran1, Christian Vestergaard3.   

Abstract

Atopic dermatitis is a common inflammatory skin disease that can affect both children and adults. It is a chronic disease with recurrent, highly pruritic eczematous lesions. Topical treatment with anti-inflammatory agents is the mainstay of treatment for atopic dermatitis, either in a reactive or proactive approach according to severity of the disease and always in combination with daily application of an emollient cream. Several studies have shown that proactive therapy with either topical corticosteroids or topical calcineurin inhibitors is significantly superior at reducing the number of flares and increasing the interval between flares compared with reactive therapy in patients with moderate and severe disease. The risk of side effects is considered low, and there seem to be no extra economic costs related to this treatment approach. Proactive therapy is an advisable treatment option for patients with moderate and severe atopic dermatitis to gain prolonged disease control; however, long-term safety data and data on when to stop do not yet exist.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34322849     DOI: 10.1007/s40257-021-00629-0

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  63 in total

Review 1.  New insights into the epidemiology of childhood atopic dermatitis.

Authors:  C Flohr; J Mann
Journal:  Allergy       Date:  2013-11-21       Impact factor: 13.146

2.  Childhood atopic dermatitis and risk of attention deficit/hyperactivity disorder: A cohort study.

Authors:  Jette Lindorff Riis; Christian Vestergaard; Mette S Deleuran; Morten Olsen
Journal:  J Allergy Clin Immunol       Date:  2016-03-26       Impact factor: 10.793

3.  Stereological quantification of lymphocytes in skin biopsies from atopic dermatitis patients.

Authors:  A R Ellingsen; F B Sørensen; J O Larsen; M S Deleuran; K Thestrup-Pedersen
Journal:  Acta Derm Venereol       Date:  2001 Aug-Sep       Impact factor: 4.437

4.  Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

Authors:  Mayte Suárez-Fariñas; Suzanne J Tintle; Avner Shemer; Andrea Chiricozzi; Kristine Nograles; Irma Cardinale; Shenghui Duan; Anne M Bowcock; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2011-04       Impact factor: 10.793

Review 5.  [Classification and treatment of itch].

Authors:  Hjalte H Andersen; Jesper Elberling
Journal:  Ugeskr Laeger       Date:  2019-03-11

6.  Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults.

Authors:  J Ring; A Zink; B W M Arents; I A Seitz; U Mensing; M C Schielein; N Wettemann; G de Carlo; A Fink-Wagner
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-06-06       Impact factor: 6.166

Review 7.  The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Authors:  Patrick M Brunner; Emma Guttman-Yassky; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2017-04       Impact factor: 10.793

Review 8.  Atopic dermatitis.

Authors:  Sinéad M Langan; Alan D Irvine; Stephan Weidinger
Journal:  Lancet       Date:  2020-08-01       Impact factor: 79.321

Review 9.  Cellular and molecular immunologic mechanisms in patients with atopic dermatitis.

Authors:  Thomas Werfel; Jean-Pierre Allam; Tilo Biedermann; Kilian Eyerich; Stefanie Gilles; Emma Guttman-Yassky; Wolfram Hoetzenecker; Edward Knol; Hans-Uwe Simon; Andreas Wollenberg; Thomas Bieber; Roger Lauener; Peter Schmid-Grendelmeier; Claudia Traidl-Hoffmann; Cezmi A Akdis
Journal:  J Allergy Clin Immunol       Date:  2016-08       Impact factor: 10.793

Review 10.  New treatments in atopic dermatitis.

Authors:  Neha Puar; Raj Chovatiya; Amy S Paller
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-17       Impact factor: 6.347

View more
  1 in total

1.  Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo.

Authors:  Qing Wu; Xiumei Mo; Ying Lin; Junfeng Liu; Siqi Ye; Yu Zhang; Xingxing Fan; Dacan Chen; Fenggen Yan
Journal:  Ann Transl Med       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.